Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).

Bernd Gansbacher

doi:10.1002/jgm.390

Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).

Bernd Gansbacher

Lehrstuhl für Experimentelle Onkologie und Therapieforschung

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

50 Zitate (Scopus)

Originalsprache	Englisch
Seiten (von - bis)	261-262
Seitenumfang	2
Fachzeitschrift	Journal of Gene Medicine
Jahrgang	5
Ausgabenummer	3
DOIs	https://doi.org/10.1002/jgm.390
Publikationsstatus	Veröffentlicht - März 2003

Zugriff auf Dokument

10.1002/jgm.390

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{385695cc8a8240d191cd99d3205da1d2,

title = "Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).",

author = "Bernd Gansbacher",

year = "2003",

month = mar,

doi = "10.1002/jgm.390",

language = "English",

volume = "5",

pages = "261--262",

journal = "Journal of Gene Medicine",

issn = "1099-498X",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).

AU - Gansbacher, Bernd

PY - 2003/3

Y1 - 2003/3

UR - http://www.scopus.com/inward/record.url?scp=0043033652&partnerID=8YFLogxK

U2 - 10.1002/jgm.390

DO - 10.1002/jgm.390

M3 - Article

C2 - 12666192

AN - SCOPUS:0043033652

SN - 1099-498X

VL - 5

SP - 261

EP - 262

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

IS - 3

ER -